FDA Inspection 1250041 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on Sep 13, 2024 in Scotch Plains, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Scotch Plains, NJ (United States)